"Medical device funding is hitting levels we haven't seen since 2021, with investors pouring billions into diagnostics and imaging companies. While innovation has raced ahead, a fundamental problem still hasn't changed: Critical medical hardware like MRI machines cost millions of dollars and is limited to large hospitals. So how do you take one of the most expensive, hospital-bound technologies and make it available anywhere?"
"While innovation has raced ahead, a fundamental problem still hasn't changed: Critical medical hardware like MRI machines cost millions of dollars and is limited to large hospitals. So how do you take one of the most expensive, hospital-bound technologies and make it available anywhere? Evan Kervella, founder and CEO of Paris-based startup Chipiron, joined Equity to walk us through the problem and his vision for solving it."
Medical device funding has returned to 2021 levels, with investors pouring billions into diagnostics and imaging companies. Innovation in medical technology has accelerated, yet a persistent problem remains: critical hardware such as MRI machines costs millions and is confined to large hospitals. The high capital cost and size of MRI systems limit access outside major medical centers. The central challenge is transforming one of the most expensive, hospital-bound technologies into equipment that can be deployed broadly and affordably. Paris-based startup Chipiron, led by founder and CEO Evan Kervella, is developing approaches and a vision aimed at making MRI technology available anywhere.
Read at TechCrunch
Unable to calculate read time
Collection
[
|
...
]